Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 1;42(7):1109-1132.
doi: 10.1097/HJH.0000000000003739. Epub 2024 Apr 11.

Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'

Costas Thomopoulos  1 , Jana Brguljan Hitij  2 , Tine De Backer  3 , Eugenia Gkaliagkousi  4 , Reinhold Kreutz  5 , Marilucy Lopez-Sublet  6 , Maria Marketou  7 , Anastasia S Mihailidou  8   9 , Agnieszka Olszanecka  10 , Antoinette Pechère-Bertschi  11 , Mariana Paula Pérez  12 , Alexandre Persu  13 , Federica Piani  14 , Thenral Socrates  15 , Katarzyna Stolarz-Skrzypek  10 , Renata Cífková  16   17
Affiliations
Review

Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'

Costas Thomopoulos et al. J Hypertens. .

Abstract

Hypertensive disorders in pregnancy (HDP), remain the leading cause of adverse maternal, fetal, and neonatal outcomes. Epidemiological factors, comorbidities, assisted reproduction techniques, placental disorders, and genetic predisposition determine the burden of the disease. The pathophysiological substrate and the clinical presentation of HDP are multifarious. The latter and the lack of well designed clinical trials in the field explain the absence of consensus on disease management among relevant international societies. Thus, the usual clinical management of HDP is largely empirical. The current position statement of the Working Group 'Hypertension in Women' of the European Society of Hypertension (ESH) aims to employ the current evidence for the management of HDP, discuss the recommendations made in the 2023 ESH guidelines for the management of hypertension, and shed light on controversial issues in the field to stimulate future research.

PubMed Disclaimer

References

    1. Thomopoulos C, Brguljan J, Cifkova R, Persu A, Kreutz R. Mild chronic hypertension in pregnancy: to treat or wait? Blood Press 2022; 31:121–124.
    1. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ. Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011; 2011:214365.
    1. Duffy J, Cairns AE, Richards-Doran D, van ’t Hooft J, Gale C, Brown M, et al. International Collaboration to Harmonise Outcomes for Preeclampsia (iHOPE). A core outcome set for preeclampsia research: an international consensus development study. BJOG 2020; 127:1516–1526.
    1. Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol 2022; 226:S1222–S1236.
    1. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023; 41:1874–2071.

MeSH terms

Substances